The Scientific and Research Team at Sigilon Therapeutics focuses on developing and optimizing immune-protected, engineered human cells to restore normal physiological functions in a variety of chronic diseases. This team conducts cutting-edge research, develops bioanalytical assays, manages preclinical studies, and ensures efficient lab operations to advance Sigilon's innovative cell therapies from discovery through development stages.
Andrew Torres
Associate Scientist
Drew Tietz
Principal Scientist
Ilanit Arakanchi Wol...
Associate Scientist
Junianna Borgia
ICT Research Assistant
Kathleen Barrett
Manager, Preclinical
Lauren Sohn
Scientist
Lin Nie
Principal Scientist (bioanalyt...
Marylou Ross
Senior Associate Engineer - Pr...
Monica Keating
Prinical Associate Scientist
Samuel Andrews
Senior Associate Lab Operation...
View all